Fulltext search has been disabled for Key Event Relationships (KERs) at this time. If you need this feature, send an email to aopwiki@googlegroups.com

Queries Key Event Relationship (KER) titles
Filter by Upstream Key Event title
Filter by Downstream Key Event title
Filter by AOP title

Showing 2901 to 2925 of 3119 KERs

Clear Table Filters
ID Upstream Event Downstream Event Creation Date Last Updated AOPs
94 78: Reduction, Cumulative fecundity and spawning 360: Decrease, Population growth rate Nov 29, 2016 Mar 20, 2017
2142 78: Reduction, Cumulative fecundity and spawning 361: Decline, Population May 25, 2020 May 25, 2020 None
2924 78: Reduction, Cumulative fecundity and spawning 442: Decreased, Population trajectory May 22, 2023 May 22, 2023
3228 1610: Reduction, DHEA 1690: Decrease, circulating testosterone levels May 24, 2024 Apr 8, 2025
123 106: Reduction, Eggshell thickness 253: N/A, Reproductive failure Nov 29, 2016 Dec 3, 2016
460 446: Reduction of testosterone 414: Increase, Luteinizing hormone (LH) Nov 29, 2016 Dec 3, 2016 None
608 446: Reduction of testosterone 348: Malformation, Male reproductive tract Nov 29, 2016 Dec 2, 2016 None
1649 446: Reduction of testosterone 520: Decreased sperm quantity or quality in the adult, Decreased fertility Aug 11, 2017 Aug 11, 2017 None
143 129: Reduction, Gonadotropins, circulating concentrations 274: Reduction, Testosterone synthesis by ovarian theca cells Nov 29, 2016 Mar 20, 2017
667 64: Reduction, Ionotropic GABA receptor chloride channel conductance 669: Reduction, Neuronal synaptic inhibition Nov 29, 2016 Apr 29, 2019
683 669: Reduction, Neuronal synaptic inhibition 682: Generation, Amplified excitatory postsynaptic potential (EPSP) Nov 29, 2016 May 15, 2018
1018 981: Reduction, NFAT/AP-1 complex formation 982: Suppression, Suppression in mixed lymphocyte reaction (MLR) Nov 29, 2016 Dec 3, 2016 None
1019 981: Reduction, NFAT/AP-1 complex formation 983: Suppression, Suppression of T-cell dependent antibody response (TDAR) Nov 29, 2016 Dec 3, 2016 None
1020 981: Reduction, NFAT/AP-1 complex formation 984: Impairment, T-cell dependent antibody response Nov 29, 2016 Dec 3, 2016 None
1021 981: Reduction, NFAT/AP-1 complex formation 985: Relief, Relief of atopic dermatitis Nov 29, 2016 Dec 3, 2016 None
1022 981: Reduction, NFAT/AP-1 complex formation 986: Impairment of TDAR Nov 29, 2016 Dec 3, 2016 None
1256 981: Reduction, NFAT/AP-1 complex formation 1203: Suppression, Suppression of production of cytotoxic T-cells Nov 29, 2016 Dec 3, 2016 None
1257 981: Reduction, NFAT/AP-1 complex formation 1204: Suppression, Suppression of T-cell dependent antibody production Nov 29, 2016 Dec 3, 2016 None
1509 981: Reduction, NFAT/AP-1 complex formation 1202: Suppression, IL-2 and IL-4 production May 19, 2017 Jun 27, 2021
252 219: Reduction, Plasma 17beta-estradiol concentrations 285: Reduction, Vitellogenin synthesis in liver Nov 29, 2016 Mar 20, 2017
253 219: Reduction, Plasma 17beta-estradiol concentrations 309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development Nov 29, 2016 Nov 29, 2016 None
392 219: Reduction, Plasma 17beta-estradiol concentrations 405: disrupted, ovarian cycle Nov 29, 2016 Dec 3, 2016
1386 219: Reduction, Plasma 17beta-estradiol concentrations 221: Reduction, Plasma vitellogenin concentrations Mar 17, 2017 Oct 18, 2018
2922 219: Reduction, Plasma 17beta-estradiol concentrations 2139: Reduction, the ratio of E2/11-KT in plasma May 22, 2023 May 22, 2023
255 221: Reduction, Plasma vitellogenin concentrations 309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development Nov 29, 2016 Mar 20, 2017